{
  "note_id": "gold_t2dm_006",
  "scenario": "t2dm",
  "persona": "gold",
  "note_text": "**Clinical Note**\n\n**Patient Name:** Maria Garcia  \n**Age:** 28 years  \n**Gender:** Female  \n**Date of Visit:** [Insert Date]  \n**Occupation:** Registered Nurse  \n**BMI:** 32.4  \n\n**Chief Complaint:**  \n\"Diabetes follow-up\"\n\n**History of Present Illness:**  \nMaria Garcia is a 28-year-old female with a 3-year history of Type 2 Diabetes Mellitus, presenting for routine management. Her diabetes is currently poorly controlled with an HbA1c of 9.5%. She reports fasting glucose readings between 160-220 mg/dL and postprandial readings between 180-250 mg/dL. Maria is currently on Metformin 1000mg twice daily, which she takes consistently, but reports occasional gastrointestinal upset that she is managing. She denies any episodes of hypoglycemia. Her last eye examination was 8 months ago and showed no retinopathy. Today's foot exam was normal. She has hypertension, well-controlled on Lisinopril, and hyperlipidemia on Atorvastatin. Maria leads a sedentary lifestyle, engages in minimal exercise, struggles with portion control, and consumes soda daily. She denies polyuria, polydipsia, weight loss, or visual changes but notes occasional tingling in her feet. No history of gestational diabetes and she is not currently planning pregnancy. Her menstrual cycles are regular.\n\n**Review of Systems:**  \n- **General:** No fevers, fatigue; reports occasional tingling in feet.\n- **HEENT:** No visual changes, recent eye exam normal.\n- **Cardiovascular:** No chest pain, palpitations.\n- **Respiratory:** No cough, shortness of breath.\n- **Gastrointestinal:** Occasional GI upset with Metformin.\n- **Genitourinary:** No polyuria, polydipsia.\n- **Musculoskeletal:** No joint pain.\n- **Neurological:** Occasional tingling in feet.\n- **Endocrine:** No weight loss.\n- **Skin:** No wounds or calluses on feet.\n\n**Past Medical History:**  \n- Type 2 Diabetes Mellitus, 3 years  \n- Hypertension  \n- Hyperlipidemia  \n\n**Medications:**  \n- Metformin 1000mg twice daily  \n- Lisinopril 20mg daily  \n- Atorvastatin 20mg daily  \n\n**Allergies:**  \nNo known drug allergies.\n\n**Social History:**  \n- Occupation: Registered Nurse  \n- Lifestyle: Sedentary, minimal exercise  \n- Diet: Struggles with portion control, drinks soda daily  \n- Tobacco/Alcohol/Drug use: Denies  \n\n**Physical Examination:**  \n- **Vital Signs:** BP 128/78 mmHg, HR 78, Weight 185 lbs, BMI 32.4, Temperature 98.6\u00b0F  \n- **General:** Alert, obese, pleasant demeanor  \n- **Cardiovascular:** Regular rate and rhythm, no murmurs, peripheral pulses 2+ bilaterally  \n- **Respiratory:** Clear to auscultation bilaterally  \n- **Extremities:** Monofilament test shows protective sensation intact, skin intact, no edema  \n- **Feet:** No deformities, nails trimmed, no fungal infection  \n\n**Assessment and Plan:**  \n1. **Type 2 Diabetes Mellitus, poorly controlled (ICD-10: E11.65)**\n   - Add Semaglutide 0.25mg subcutaneous weekly, increase to 0.5mg after 4 weeks.\n   - Continue Metformin 1000mg twice daily.\n   - Order HbA1c in 3 months.\n   - Referral to diabetes educator for nutrition counseling.\n   - Lifestyle counseling to eliminate sugar-sweetened beverages, portion control, and increase physical activity to 150 min/week.\n   - Weight loss goal: 5-10% body weight over 6 months.\n   - Patient education on new medication, glucose targets, and lifestyle modifications.\n\n2. **Obesity (ICD-10: E66.9)**\n   - Lifestyle modifications as above for weight management.\n\n3. **Essential Hypertension, controlled (ICD-10: I10)**\n   - Continue Lisinopril 20mg daily.\n\n4. **Hyperlipidemia (ICD-10: E78.5)**\n   - Continue Atorvastatin 20mg daily.\n\n5. **Preventive Care:**\n   - Referral to ophthalmology for annual dilated eye exam.\n   - Order annual kidney function tests.\n   - Ensure flu vaccination and check pneumococcal vaccine status.\n   - Discuss contraception given medication changes.\n\n**Time Spent:**  \n25 minutes with extensive medication counseling and lifestyle education.\n\n**Billing Level:**  \n99214 (Established patient, moderate to high complexity due to uncontrolled chronic disease)\n\n**Medical Decision Making:**  \nMaria's diabetes management is challenging due to elevated HbA1c of 9.5% despite Metformin. Added Semaglutide for its dual benefit in glucose control and weight management, and discussed potential side effects and injection technique. Emphasized importance of lifestyle changes in managing diabetes and reducing cardiovascular risk. Addressed barriers related to her work schedule and dietary habits. Screening for complications is up-to-date except for ophthalmology, for which a referral has been placed. Discussed contraception due to potential pregnancy contraindications with current treatment plan.",
  "demographics": {
    "age": 28,
    "gender": "F",
    "occupation": "registered nurse",
    "name": "Maria Garcia"
  },
  "generated_at": "2026-02-14T01:56:20.469557",
  "ground_truth_scores": {
    "completeness": 92,
    "accuracy": 95,
    "compliance": 90,
    "risk": 88,
    "clarity": 94
  }
}